Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,703 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,753
Recruiting: 1,520
Ph III recruiting: 168
Growth YoY: +6.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,319)

clinicaltrialsPublishedShowing 251–300 of 3,388 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04969315	TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma	recruiting	Phase 1 / Phase 2	35	Portage BiotechINDUSTRY	1	Sep 15, 2026	clinicaltrials
NCT05115474	Study of Screening Brain MRIs in Stage IV Breast Cancer	recruiting	Phase 2	170	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 15, 2026	clinicaltrials